Acute myeloid leukaemia (AML) comprises a heterogeneous group of hematologic neoplasms characterized by diverse combinations of genetic, phenotypic and clinical features representing a major challenge for the development of targeted therapies. 
bioenergetics needs. 9, 10 This metabolic reprogramming provides tumour cells with advantages necessary for sustaining their high proliferation rates, such as the rapid generation of ATP and intermediates for the synthesis of fatty acids, nucleotides and amino acids. 11 Studies in AML cell lines and human primary AML blasts correlated metabolic reprogramming with chemo-resistance showing that enhanced glycolysis decreases the AML cells sensitivity to cytarabine, while the inhibition of glycolysis potentiates the cytotoxicity of this anti-leukaemia agent. 12 Furthermore, it was also proposed that the extent of myeloblast glycolysis may be an effective method to determine the pretreatment prognosis of AML. 13 Importantly, the metabolic reprogramming in cancer cells is mainly associated with the deregulation of the major nutrient-sensing pathways: the AMP-activated protein kinase (AMPK), the mammalian target of rapamycin complex 1 (mTORC1) and the phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase B (AKT). 14 Deregulation of these signalling pathways, which enhance cellular survival and proliferation, seems to cooperate with genetic abnormalities to the pathogenesis of AML. 15 In fact, while PI3K/AKT pathway is often found activated in AML, mTORC1 appears to be active in all reported AML cases. 16, 17 Both mTORC1 and AKT seem to contribute for the glycolytic metabolism of some AML cells and human primary AML blasts. 18, 19 Globally, it is still debatable and controversial if the deregulation of AMPK, mTORC1 and/or AKT in AML cells would function as a tumour suppressor or promoter. 15, 17, [20] [21] [22] [23] [24] [25] [26] Nevertheless, once activated, AMPK [27] [28] [29] and AKT 29, 30 may control macroautophagy in mTORC1-(in)dependent pathway(s). Macroautophagy, hereafter referred as to autophagy, is a multi-step self-degradative process by which cytoplasmic content, such as long-lived proteins and superfluous/damaged organelles, is delivered to lysosomes for degradation. 31 Deregulation of autophagy has been extensively described in AML acting both as tumour promoting and suppressing. 26, [32] [33] [34] Therefore, the elucidation of the interconnection between the nutrient-sensing players, autophagy and energetic metabolism is of major relevance to understand cellular homeostasis and survival of AML cells. Herein, results provide evidence that different AML cells present diverse metabolic profiles.
Indeed, whereas KG-1 cells exhibited preferential OXPHOS metabolism with co-activation of AMPK and mTORC1 associated with increased autophagy flux, NB-4 and HL-60 cells displayed high intracellular ATP levels and a glycolytic profile mainly associated with AKT/mTORC1 activation and low autophagy flux. Inhibition of AKT is disclosed as a promising target for therapeutic intervention in some scenarios while inhibition of AMPK and mTORC1 has no major impact on KG-1 cells survival.
| MATERIAL AND METHODS

| Cell culture
The NB-4, HL-60 and KG-1 cell lines were obtained from the German 
| Quantification of the intracellular ATP levels
NB-4, HL-60 and KG-1 cells were plated at 0.5 9 10 6 cells/mL/well, cultured for 24 hours, collected and the pellet reserved. Intracellular ATP levels were determined using the ENLITEN ATP Assay System from Promega â according to the manufacturer's instructions. At least, 3 independent biological replicates were performed. nuclei. An epifluorescence microscope (BX61 microscope with an Olympus DP70 camera) was used to slide visualization, and images were analysed with ImageJ â Software (National Institutes of Health).
| Immunofluorescence assay
At least, 3 independent biological replicates were performed.
| Statistical analysis
All data are reported as the mean AE standard error of the mean (SEM). Statistical analysis was performed using the 2-away ANOVA and Bonferroni's post hoc tests to denote significant differences between the tested groups for the annexin V/PI approach. Student's t test was applied to compare the extracellular glucose and lactate levels between untreated and MK-2206 treated HL-60 and NB-4 cells. The one-way ANOVA and Tukey's post hoc tests were used to compare the tested groups for all the other approaches. A P-value lower than 0.05 was assumed to denote a significant difference.
| RESULTS
| Glycolytic versus oxidative metabolism of AML cells
Metabolic reprogramming, the switch from oxidative to glycolytic metabolism, ensures a rapid production of ATP and biosynthetic precursors that confer adaptive advantages and long-term maintenance to cancer cells. 10, 35 Although enhanced glucose metabolism was recently described in AML, 12, 13 | 4809
showed that the tested AML cells display a distinct energetic metabolism, with NB-4 and HL-60 cells being highly dependent on the glycolytic metabolism while KG-1 cells appear to be more dependent on OXPHOS metabolism.
| Complexity of the mTORC1 activation network and autophagy regulation in AML cells
The reprogramming of energetic metabolism in tumour cells is mainly driven by the deregulation of the nutrient-sensing pathways. 14 The orchestrated metabolic network perpetuated by the nutrient-sensing pathways converges on the control of cellular catabolic processes required to maintain cellular homeostasis, such as autophagy. 42 Given the central, although controversial, role of autophagy in the AML pathogenesis, 33, 43 it is critical to comprehend not only its regulation but also its crosstalk with the metabolic signals. Annexin V/PI data were analysed using 2-way ANOVA and Bonferroni's post hoc test. *P < .05; **P < .01; ***P < .001
Therefore, autophagy was evaluated in the AML cells by immunoblotting analysis of the Atg5-Atg12 complex, LC3 processing (I and II) and LC3 puncta. 44 KG-1 cells presented the highest Atg5-Atg12 complex protein levels ( Figure 3A ) associated with the highest autophagy flux, as reflected by the LC3 processing ( Figure 3B ).
Immunoblotting results of the LC3 processing were corroborated by the immunostaining of LC3 showing higher number of LC3 puncta in KG-1 cells than in NB-4 and HL-60 cells ( Figure 3C ), which strengthens our hypothesis that autophagy is up-regulated in KG-1 cells.
Overall, the data herein presented showed a mTORC1 activation in all tested AML cells, whereas AKT activation was mainly observed in NB-4 and HL-60 cells. Importantly, our data strongly suggest that AMPK and mTORC1 are constitutively activated in KG-1 cells. This distinct nutrient-sensing pathway activation profile is associated with F I G U R E 2 NB-4 and HL-60 cells exhibit AKT activation while KG-1 cells display a constitutive AMPK and mTORC1 co-activation. NB-4, HL-60 and KG-1 cells were maintained for 24 h in normal growth medium. (A) Activation of AKT was determined by immunoblotting analysis of phosphorylated (Ser473) AKT levels. Activation of (B) mTORC1 and (C) S6K was also assessed by immunoblotting analysis of phosphorylated (Ser2448) mTORC1 and phosphorylated (Thr389) S6K levels, respectively. Activation of (D) AMPK and (E) ACC was evaluated by immunoblotting analysis of phosphorylated (Thr172) AMPK and phosphorylated (Ser79) ACC levels, respectively. Actin was used as loading control. Densitometric analysis was performed, and bands were quantified using the ImageLab4.1 TM software. The results presented as mean AE SEM of, at least, 3 independent biological replicates. One-way ANOVA and Tukey's post hoc test were used to compare the densitometric analysis of pAKT/AKT, pmTORC1/mTORC1, pS6K/S6K, pAMPK/AMPK and pACC/ACC ratios between NB-4, HL-60 and KG-1 cells. *P < .05; ***P < .001 an up-regulation of autophagy in KG-1 cells independently of mTORC1. Figure 4A,B) , ascribing to the AKT-mTORC1 axis a key role on the autophagy regulation of NB-4 and HL-60 cells. On the other hand, to decipher the relevance of the AMPK-mTORC1 axis in KG-1 cells, an AMPK inhibitor, compound C (CC), or a mTORC1 inhibitor, rapamycin (Rap), were used. Results presented in Figure 4C showed that CC promoted a reduction in the AMPK activation with no major impact on the mTORC1 activity (detected by the S6K phosphorylated levels), which was accompanied by a significant decline on the autophagy flux 
| Manipulation of nutrient-sensing pathways impacts on autophagy and energetic metabolism of AML cells
| Targeting nutrient-sensing pathways sensitizes NB-4 and HL-60 but has a minor impact on KG-1 cells
The impact of manipulating AKT, mTORC1 and AMPK on the survival of AML cells is still controversial. 18, 20, 21, 43, 45 Knowing that inhibition of these nutrient-sensing pathways has a major impact on autophagy and energetic metabolism of AML cells, the viability of these cells was evaluated. Data showed a significant decrease on the viability of NB-4 ( Figure 4M ) and HL-60 ( Figure 4N The therapeutic approach to AML diseases must pass through personalized therapy adapted to the heterogeneity of this group of neoplasms.
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